Copyright
©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 94914
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.94914
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.94914
Table 2 Summary of pharmacotherapy use within 24 months of liver transplantation
n | % | |
Statin use | 56 | 18.36 |
Aspirin use | 51 | 16.72 |
Metformin use | 50 | 16.39 |
Statins, aspirin or metformin use | 126 | 41.31 |
MTORi use | 85 | 27.87 |
- Citation: Chung W, Wong K, Ravindranayagam N, Tang L, Grace J, Wong D, Con D, Sinclair M, Majumdar A, Kutaiba N, Hui S, Gow P, Muralidharan V, Dobrovic A, Testro A. Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study. World J Transplant 2024; 14(3): 94914
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/94914.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.94914